At Genomic Health, we always look forward to the American Society of Clinical Oncology's annual meeting. This year's meeting promises to be exceptional in the quality and quantity of new research in genomics, and we hope to see you there!

What to look for at ASCO

A large, independent study using the Oncotype DX Breast Recurrence Score® test has been accepted for presentation at ASCO 2018.

Read our press release

Find us at Booth 12089

Over 900,000 cancer patients worldwide have benefited from Oncotype DX tests. Hear from oncologists and allied medical professionals about their experiences with the test.

Join the conversation on Twitter

Follow us on Twitter to hear about all the latest updates from ASCO.

Follow @GenomicHealth

Follow @OncotypeIQ

Making cancer care smarter.™

This site uses cookies. These cookies collect information about how visitors use a website, for instance which pages visitors go to most often, and if they get error messages from web pages. These cookies don’t collect information that identifies a visitor. All information these cookies collect is used only to improve the website. By visiting this website, you agree that we can place these types of cookies on your device.